Therefore, the current study analysed the relationship between these markers and determined whether serum AGEs, RAGE, sRAGE, IGF-1, and IGF-1R function as influencing variables for the risk of developing CRC in patients with T2DM. The gene discussed is IGF1; the disease is colorectal carcinoma.